Q & A
Our Q&A interviews offer investors a chance to listen a conversation with C-Suite Executives of UK-listed companies.
Share:
Jeremy Skillington of Poolbeg Pharma discusses their Nasdaq partnership for development
17th Oct 2023 06:59
0
See more in series
0